Givaudan | GIVN - Assets


Givaudan reported CHF11.86B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Air Liquide EUR 56.28B 4.36B Jun/2026
Akzo Nobel EUR 16.13B 647M Jun/2026
Anheuser-Busch USD 218.39B 423M Jun/2026
Arkema EUR 14.17B 48.4M Jun/2026
Associated British Foods GBP 19.29B 608M Dec/2025
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.29B 659M Jun/2026
Beiersdorf EUR 12.76B 166M Dec/2025
British American Tobacco GBP 108.39B 902M Jun/2026
Covestro EUR 13.47B 245M Dec/2025
Croda International GBP 3.51B 70.1M Dec/2024
Danone EUR 48.62B 3.55B Jun/2026
Diageo GBP 46.85B 3.43B Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.29B 174.35M Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
Heineken EUR 58.04B 4.29B Jun/2026
Henkel EUR 36.5B 3.96B Jun/2026
International Flavors Fragrances USD 25.15B 10M Jun/2026
Johnson Matthey GBP 5.97B 142M Jun/2026
Kerry EUR 11.15B 479.8M Jun/2026
Lonza CHF 18.97B 164M Dec/2025
L'Oréal EUR 66.35B 4.53B Jun/2026
Merck EUR 52.69B 383M Jun/2026
Nestle CHF 128.38B 1.23B Jun/2026
Pernod Ricard EUR 37.68B 596M Dec/2025
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
SGS CHF 6.75B 148M Dec/2024
Sika AG CHF 15.15B 245M Dec/2025
Solvay EUR 6.08B 122M Jun/2026
Tate & Lyle GBP 3.67B 67M Jun/2026
Umicore EUR 10.06B 603.5M Jun/2026
Victrex GBP 505.3M 61.6M Jun/2026